Gottlieb P A, Eisenbarth G S
Barbara Davis Center for Childhood Diabetes, University of Colorado Health Sciences Center, Denver 80262, USA.
J Autoimmun. 1996 Apr;9(2):277-81. doi: 10.1006/jaut.1996.0035.
Autoimmunity to the pancreatic beta cell appears to be a chronic disorder which in some individuals progresses to overt type I diabetes [1]. Studies of offspring or siblings of patients with type I diabetes (IDDM) and discordant twins who have been followed for over 30 years are shedding new light on the disorder. Recent advances in molecular biological techniques have resulted in our ability to identify novel autoantigens and rapidly develop sensitive and specific tests to detect beta cell autoimmunity. The ability to cost-effectively screen the general population for diabetes susceptibility is rapidly becoming a reality. Animal models of diabetes such as the non-obese diabetes (NOD) mouse have provided insights into both pathogenesis of this disease and potentially into the prevention of diabetes as well. We will attempt to use our knowledge gained from studies of man and the NOD mouse to illustrate what we know and need to learn in order to prevent type I diabetes.
对胰腺β细胞的自身免疫似乎是一种慢性疾病,在某些个体中会发展为显性I型糖尿病[1]。对I型糖尿病(IDDM)患者的后代或兄弟姐妹以及已随访30多年的不一致双胞胎的研究,为这种疾病带来了新的认识。分子生物学技术的最新进展使我们有能力识别新的自身抗原,并迅速开发出灵敏且特异的检测方法来检测β细胞自身免疫。以具有成本效益的方式对普通人群进行糖尿病易感性筛查的能力正迅速成为现实。糖尿病动物模型,如非肥胖糖尿病(NOD)小鼠,不仅为这种疾病的发病机制提供了见解,也为糖尿病的预防提供了潜在的思路。我们将尝试利用从对人类和NOD小鼠的研究中获得的知识,来说明为预防I型糖尿病我们已知的内容以及需要了解的内容。